Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,901 INR
Change Today +30.80 / 1.65%
Volume 948.6K
LPC On Other Exchanges
Symbol
Exchange
Natl India
OTC US
As of 7:06 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

lupin ltd (LPC) Snapshot

Open
1,898
Previous Close
1,870
Day High
1,917
Day Low
1,892
52 Week High
04/8/15 - 2,115
52 Week Low
07/10/14 - 1,012
Market Cap
855.2B
Average Volume 10 Days
955.2K
EPS TTM
53.54
Shares Outstanding
449.9M
EX-Date
07/14/15
P/E TM
35.5x
Dividend
7.50
Dividend Yield
0.16%
Current Stock Chart for LUPIN LTD (LPC)

Related News

No related news articles were found.

lupin ltd (LPC) Related Businessweek News

No Related Businessweek News Found

lupin ltd (LPC) Details

Lupin Limited, a pharmaceutical company, produces, develops, and markets a range of branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. It offers formulations for use in the areas of cardiovascular, diabetology, asthma, pediatric, central nervous system (CNS), gastro-intestinal, anti-diabetic, anti-infective, NSAID, anti- tuberculosis, cephalosporin, gynaecology, and other therapeutic areas; and APIs for use in therapeutic areas of antibiotics, anti-tuberculosis, cardiovascular, CNS, analgesics, and anti-gout. The company also develops drug delivery technologies; and creates and develops biosimilars for various therapeutic indications, such as oncology, inflammation, antivirals, osteoporosis, rheumatoid arthritis, and ophthalmics. In addition, it engages in the novel drug discovery and development programs for use in the treatment of CNS disorders, oncology, immunology, pain and inflammation, infections, and metabolic/endocrine disorders. Lupin Limited has a strategic licensing agreement with InspiRX Inc. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

15,000 Employees
Last Reported Date: 06/27/15
Founded in 1968

lupin ltd (LPC) Top Compensated Officers

Founder, Chairman, Member of Share Transfer C...
Total Annual Compensation: 36.7M
Chief Financial Officer and Member of Risk Ma...
Total Annual Compensation: 79.2M
Vice Chairman, Chairman of Share Transfer Com...
Total Annual Compensation: 139.4M
Managing Director, Executive Director, Member...
Total Annual Compensation: 81.5M
Executive Director, Member of Share Transfer ...
Total Annual Compensation: 4.6M
Compensation as of Fiscal Year 2015.

lupin ltd (LPC) Key Developments

Lupin Ltd. Proposes Dividend for the Year Ended March 31, 2015

Lupin Ltd. at its AGM to be held on July 23, 2015, proposed dividend at 375% that is INR 7.50 per equity share of the face value of INR 2 each for the year ended March 31, 2015. The register of members & share transfer books of the company will remain closed from July 16, 2015 to July 23, 2015 (both days inclusive) for the purpose of payment of dividend & Annual General Meeting (AGM) of the company.

Lupin Limited, Board Meeting, Jun 26, 2015

Lupin Limited, Board Meeting, Jun 26, 2015. Agenda: To consider allotment of 49,954 fully paid up equity shares of INR 2 each.

Lupin Limited, Board Meeting, Jun 22, 2015

Lupin Limited, Board Meeting, Jun 22, 2015. Agenda: To consider raising of funds up to INR 75,000 million through issue of securities.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LPC:IN 1,900.95 INR +30.80

LPC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $63.07 USD -1.70
H Lundbeck A/S kr136.30 DKK +0.80
Ipca Laboratories Ltd 690.70 INR -7.95
Krka dd Novo mesto €65.00 EUR 0.00
Piramal Enterprises Ltd 966.05 INR +10.50
View Industry Companies
 

Industry Analysis

LPC

Industry Average

Valuation LPC Industry Range
Price/Earnings 35.1x
Price/Sales 6.6x
Price/Book 9.5x
Price/Cash Flow 29.6x
TEV/Sales 6.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LUPIN LTD, please visit www.lupinworld.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.